3-Step treatment efficient for small pupils

Article

According to recently published data, a 3-step treatment protocol is an efficient way to ensure good safety margins for patients with pupils smaller than 5.5 mm

According to recently published data, a 3-step treatment protocol is an efficient way to ensure good safety margins for patients with pupils smaller than 5.5 mm undergoing femtosecond laser-assisted cataract surgery.

The study, led by Dr Ina Conrad-Hengerer (Center for Vision Science, Ruhr University Eye Hospital, Bochum, Germany), examined eyes with an intraoperative pupil size smaller than 5.5 mm to evaluate the efficacy of a 3-step treatment to achieve larger pupil sizes before femtosecond laser-assisted cataract surgery. This 3-step process consisted of initially administering intracameral epinephrine solution, then using additional viscomydriasis and thirdly implantation of a Malyugin ring pupil expander.

Out of 850 eyes that were scheduled to receive cataract surgery, 40 underwent the sequential treatments for pupil expansion. Of this group, 7% only required the first step to achieve a pupil size larger than 5.5 mm, 25% required additional voscomydriasis and 68% needed the pupil expander as well. The team found that the most frequent comorbidities were pseudoexfoliation of the lens capsule (30%) and intraoperative floppy-iris syndrome (12.5%).

Based on this study, it was deemed that the 3-step treatment allowed an increased efficiency and safety of femtosecond laser-assisted cataract surgery in eyes with a small pre-op pupil size.

For more detailed information please view the abstract from the Journal of Cataract & Refractive Surgery.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.